dasatinib
SpainDrugs containing this active substance
-
It is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age, as well as Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children at least 1 year of age, and blast crisis CML in adults who have not responded to other treatments.
Form: tablets, film-coated
Active substance Dosage dasatinib 50 mg Manufacturer: Laboratorio Stada S.L.
-
It is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age, as well as Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children at least 1 year of age, and blast crisis CML in adults who have not responded to previous treatments.
Form: tablets, film-coated
Active substance Dosage dasatinib 70 mg Manufacturer: Laboratorio Stada S.L.
-
It is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age, as well as Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children at least 1 year of age, and lymphoid blast crisis CML in adults who have not responded to other treatments.
Form: tablets, film-coated
Active substance Dosage dasatinib 50 mg Manufacturer: Viatris Limited
-
It is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age, as well as Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children at least 1 year of age, and lymphoid blast crisis CML in adults who have not responded to other treatments.
Form: tablets, film-coated
Active substance Dosage dasatinib 70 mg Manufacturer: Viatris Limited